CTTNBP2NL-SUCLA2 Fusion FISH Probe
The CTTNBP2NL-SUCLA2 Fusion FISH Probe is used to confirm a fusion of the CTTNBP2NL and SUCLA2 genes. The fusion of the CTTNBP2NL and SUCLA2 genes has been associated with Ovarian Serous Cystadenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CTTNBP2NL-SUCLA2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CTTNBP2NL-SUCLA2-20-AQAQ | 20 (40 μL) | 200 μL |
|
SUCLA2 Gene Summary
Succinyl-CoA synthetase (SCS) is a mitochondrial matrix enzyme that acts as a heterodimer, being composed of an invariant alpha subunit and a substrate-specific beta subunit. The protein encoded by this gene is an ATP-specific SCS beta subunit that dimerizes with the SCS alpha subunit to form SCS-A, an essential component of the tricarboxylic acid cycle. SCS-A hydrolyzes ATP to convert succinate to succinyl-CoA. Defects in this gene are a cause of myopathic mitochondrial DNA depletion syndrome. A pseudogene of this gene has been found on chromosome 6. [provided by RefSeq, Jul 2008]
Gene Name: Succinate-CoA Ligase ADP-forming Beta Subunit
Chromosome: CHR13: 48516790 -48575462
Locus: 13q14.2
CTTNBP2NL Gene Summary
The CTTNBP2 N-terminal Like (CTTNBP2NL) gene is located on chr1 :112938799-113003786 at 1p13.2.
Gene Name: CTTNBP2 N-terminal Like
Chromosome: CHR1: 112938799 -113003786
Locus: 1p13.2
Gene Diseases
The CTTNBP2NL SUCLA2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Ovarian Serous Cystadenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|